(Press-News.org) A new study from researchers with UCLA Health and collaborating organizations has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).
Their findings, published on August 21 in the peer-reviewed journal Circulation, offer new insights into this incurable, often-fatal disease and suggest potential new ways to treat it.
“We were surprised to find that asporin, which previously had not been linked to PAH, gets upregulated to increased levels as a response to counteract this disease process,” said Dr. Jason Hong, a pulmonary and critical care physician at UCLA Health and the study’s corresponding author. “This novel finding opens up new avenues for understanding PAH pathobiology and developing potential therapies.”
Pulmonary hypertension is a serious medical condition characterized by high blood pressure in the arteries that supply the lungs. It causes these arteries to narrow or become blocked, which, in turn, slows blood flow to the heart, requiring it to work harder to pump blood through the lungs. Eventually, the heart muscle becomes weak and begins to fail.
Need for New Therapies
According to recent estimates, PAH affects about 1% of the global population, but that number climbs to 10% in people who are 65 or older.
There’s no cure for the disease, but medications and lifestyle changes can help slow progression, manage symptoms and prolong life.
The urgent need for new therapies, combined with the potential of multiomics – an integrated approach to drive discovery across multiple levels of biology – inspired Hong and research colleagues, including co-first author Lejla Medzikovic and senior author Mansoureh Eghbali to take a deep dive into the disease. Both work at UCLA’s Eghbali Laboratory.
Methodology
For the study, the researchers applied novel computational methods, including transcriptomic profiling and deep phenotyping, to lung samples of 96 PAH patients and 52 control subjects without the condition from the largest multicenter PAH lung biobank available to-date. They integrated this data with clinical information, genome-wide association studies, graphic models of probabilities and multiomics analysis.
“Our detailed analysis found higher levels of asporin in the lungs and plasma of PAH patients, which were linked to less severe disease," Hong said.
Additionally, Medzikovic noted that their cell and living-organism experiments found that asporin inhibited pulmonary artery smooth muscle cell proliferation and a key signaling pathway that occurs with PAH.
“We also demonstrated that recombinant asporin treatment reduced PAH severity in preclinical models,” said Medzikovic.
Next Steps
Hong and colleagues plan to further investigate the mechanisms by which asporin exerts its protective effects in PAH and explore potential therapeutic applications, focusing on how to translate their findings into clinical trials.
“Asporin represents a promising new target for therapeutic intervention in pulmonary arterial hypertension,” he explained. “Enhancing asporin levels in PAH patients could potentially lead to improved clinical outcomes and reduced disease progression.”
Authors: Jason Hong, MD, PhD,* Lejla Medzikovic, PhD*, Wasila Sun, BS‡, Brenda Wong, BA‡, Gregoire Ruffenach, PhD, Christopher J. Rhodes, PhD, Adam Brownstein, MD, Lloyd L. Liang, MS, Laila Aryan, PhD, Min Li, PhD, Arjun Vadgama, Zeyneb Kurt, PhD, Tae-Hwi Schwantes- An, PhD, Elizabeth A. Mickler, MS, Stefan Graf, PhD, Melanie Eyries, PhD, Katie A. Lutz, BS, Michael W. Pauciulo, MBA, Richard C. Trembath, MD, Frederic Perros, PhD, David Montani, MD, PhD, Nicholas W. Morrell, MD, Florent Soubrier, MD, PhD, Martin R. Wilkins, MD, William C. Nichols, PhD, Micheala A. Aldred, PhD, Ankit A. Desai, MD, David-Alexandre Tregouet, PhD, Soban Umar, MD, PhD, Rajan Saggar, MD, Richard Channick, MD, Rubin M. Tuder, MD, Mark W. Geraci, MD, Robert S. Stearman, PhD†, Xia Yang, PhD†, and senior author, Mansoureh Eghbali, PhD†. Legend: *Joint first authors; ‡ Joint second authors; †Joint last authors
Funding: This work was supported by American Heart Association grant 23POST1022457 (L.M.), American Thoracic Society Early Career Investigator Award in Pulmonary Vascular Disease (J.H.), and U.S. NIH grants K08HL169982 (J.H.), R01HL147586 (M.E.), R01HL162124 (M.E.), R01HL159865 (M.E.), R01HL147883 (X.Y.), R24HL105333 (W.N. and M.P.), R01HL160941 (W.N., A.D., and M.P.), British Heart Foundation Senior Basic Science Fellowship FS/SBSRF/21/31025 (C.R.), and funding for the PHBI is provided by NHLBI R24HL123767 and by the Cardiovascular Medical Research and Education Fund (MAA).
Disclosures: Drs. Medzikovic, Hong, and Eghbali are coinventors of US provisional patent application No. 63/544,027, “Asporin in Pulmonary Hypertension.”
END
UCLA-led study unveils new insights and potential treatments for pulmonary hypertension
2024-08-21
ELSE PRESS RELEASES FROM THIS DATE:
MD Anderson research highlights for August 21, 2024
2024-08-21
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Targeting an enzyme as part of combination therapy disrupts gastric cancer progression
Many patients with gastric cancer have metastatic disease at the time of diagnosis, ...
Proatherogenic disorders of blood lipid and lipoprotein metabolism in patients with rheumatoid arthritis
2024-08-21
In the realm of chronic inflammation, lipid abnormalities are well-recognized as pivotal contributors to the progression and clinical manifestations of atherosclerosis. Particularly in rheumatoid arthritis (RA), a systemic autoimmune disorder, the immune response leads to the generation of inflammatory cytokines that profoundly alter lipid and lipoprotein metabolism. This review article delves into the latest research exploring the impact of inflammation on proatherogenic disorders of lipid and lipoprotein metabolism in RA patients, with a focus on proinflammatory cytokines.
Role of Proinflammatory Cytokines in Lipid and Lipoprotein Dysregulation
Inflammatory ...
Pioneering study shows effective regulation and monitoring is key to tackling emissions of a super-greenhouse gas
2024-08-21
New research has revealed factories globally are not properly destroying one of the most potent greenhouse gases emitted from the production of fluoropolymers like Teflon, and refrigerants.
The study investigated a known disparity between real and reported emissions of this gas, prompting calls for more countries to sign up to official agreements to limit emissions and for their Teflon factories to be independently audited to ensure compliance.
The study, published today in the journal Nature, scrutinised emissions of one of the most potent hydrofluorocarbon (HFC) greenhouse gases called trifluoromethane, also ...
Inflammation during childhood linked to onset of mental health issues in early adulthood – study reveals
2024-08-21
Children who have persistently raised inflammation are at a higher risk of experiencing serious mental health disorders including psychosis and depression in early adulthood, according to a study published today in JAMA Psychiatry.
The research lead by the University of Birmingham also found that those who had experienced inflammation at a young age were at a higher risk of developing cardiometabolic diseases such as insulin resistance - an early form of diabetes.
The study used data collected by the Avon Longitudinal Study of Parents and Children (ALSPAC) – also known as Children of the 90s – and included a total of 6,556 participants of whom 50.4% ...
Study finds sex-based disparities in outcomes after cardiac surgery
2024-08-21
Mass General Brigham researchers found that women had a lower risk of developing postoperative atrial fibrillation after surgery compared to men, but a higher risk of long-term mortality
New research suggests that women who develop postoperative atrial fibrillation (poAF) after cardiac surgery are at greater risk of death than men. A study led by Mass General Brigham researchers found that women may have protective factors against the development of poAF, but once it develops, they may be more vulnerable to its associated long-term morbidities. The researchers suggest that more vigilant monitoring and long-term ...
Study of 18 million people finds increased mental illnesses incidence following severe COVID-19, especially in unvaccinated people
2024-08-21
A new study that examined health data on 18 million people reveals higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry today [21 August], investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.
COVID-19 is associated with mental illnesses in both hospital and population-based studies. However, until now, there was limited evidence about the association of COVID-19 with ...
Nearly 90 percent of NYC transit workers have been harassed or assaulted
2024-08-21
The COVID-19 pandemic brought an increase in crime to New York City’s subways and buses. The transit system’s employees—especially female workers—have frequently been on the receiving end of attacks, according to a new study published in the Journal of Urban Health.
The study, led by researchers at the NYU School of Global Public Health, found that 89 percent of public-facing transit workers in New York City experienced harassment or violence on the job during the pandemic (2020-2023).
“Transit workers are our city’s unsung heroes—they kept New York City functioning during the COVID-19 pandemic, ...
COVID-19 and mental illnesses in vaccinated and unvaccinated people
2024-08-21
About The Study: In this cohort study, depression, serious mental illness, general anxiety, posttraumatic stress disorder, eating disorders, addiction, self-harm, and suicide were elevated during weeks 1 through 4 after COVID-19 diagnosis compared with before or without COVID-19. Incidence was lower in people who were vaccinated when they had COVID-19 and incidence was higher, and persisted longer, after hospitalization for COVID-19. The findings support recommendation of COVID-19 vaccination in the general population and ...
New heaviest exotic antimatter nucleus
2024-08-21
UPTON, N.Y. — Scientists studying the tracks of particles streaming from six billion collisions of atomic nuclei at the Relativistic Heavy Ion Collider (RHIC) — an “atom smasher” that recreates the conditions of the early universe — have discovered a new kind of antimatter nucleus, the heaviest ever detected. Composed of four antimatter particles — an antiproton, two antineutrons, and one antihyperon — these exotic antinuclei are known as antihyperhydrogen-4.
Members of RHIC’s STAR Collaboration made the discovery by using their house-sized particle detector ...
Virtual learning in kindergarten through grade 12 during the COVID-19 pandemic and chronic absenteeism
2024-08-21
About The Study: Chronic absenteeism rates were substantially higher in school districts that used virtual learning during the COVID-19 pandemic compared with in person in this cross-sectional study. Understanding how to reduce chronic absenteeism and use virtual learning without potentially negative consequences are key policy questions moving forward.
Corresponding Author: To contact the corresponding author, William N. Evans, PhD, email wevans1@nd.edu.
To access the embargoed study: ...